[1]
R. Bag and D. Saha, “Pharmacovigilance of cutaneous adverse drug reactions-a focused research in times of COVID pandemic”, Int J Basic Clin Pharmacol, vol. 12, no. 1, pp. 111–114, Dec. 2022.